Media Coverage

Media Coverage

Read how VistaGen’s intention to revolutionize mental health medicine is causing a buzz in the media.

Thepharmaletter logo image.png
New data shows strength in VistaGen’s PH94B for SAD
Read
psychiatric Times logo image.png
A Potential Benzodiazepine Replacement
Read
Medium logo image.png
Shawn Singh of VistaGen Therapeutics: 5 Ways That Businesses Can Help Promote The Mental Wellness Of Their Employees
Read
BioTuesdays logo image.png
VistaGen readies Phase 3 trial of novel, fast-acting neuroactive nasal spray in social anxiety disorder
Read
Crain's logo image.jpg
Local Biotech Firms Poised to Benefit from Rosy Venture Capital Outlook for 2021
Read
WHSV logo image
CEO of pharmaceutical company praises new, shorter, suicide hotline
Read
STAT logo image
CBC Group sets up AffaMed, EverInsight merger, eyes IPO
Read
psychiatric Times logo image
Complementing Your Psychotherapy
Read
psychiatric Times logo image
Benzodiazepines Hit With Boxed Warning by FDA
Read